Johannes-Gutenberg-Universität

Mainz 55131

0 studies enrolling now · 4 studies all time

What they study most

Congenital Heart Disease, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer

Studies at this site

• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow — Running, not enrolling
• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients — Stopped early